NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Other News > Top accolade for gestational diabetes app

Top accolade for gestational diabetes app

28 February 2020 · Listed under Digital Health from Hospital to Home, Obesity, Diet and Lifestyle, Other News

A smartphone application for women with gestational diabetes, developed at Oxford University Hospitals (OUH) and the University of Oxford, has won a national award.

GDm-Health won the MedTech, Device or Hardware Innovation Award at the HSJ Partnership Awards on Thursday (27th February).

The app was developed initially as a ‘proof-of-concept’ collaboration between OUH’s Women’s Centre and the University of Oxford’s Institute of Biomedical Engineering, with support from the NIHR Oxford Biomedical Research Centre (BRC).

Gestational diabetes mellitus affects thousands of mothers-to-be in the UK each year and can lead to serious complications, including high rates of stillbirth and congenital anomalies.

The aim of the app was to create a method that was reliable and accurate but was also convenient for women to use, as well as being cost-saving for healthcare providers.

GDm-Health has allowed clinicians to focus on women in greatest need of clinical attention, reducing the number of face-to-face appointments required, and leading to better outcomes for the pregnancies.

After successful trials and with support from the Oxford Academic Health Science Network (AHSN) the technology was commercialised by Sensyne Health as part of an agreement with OUH and the University to develop digital health technologies.

OUH Consultant Obstetrician Dr Lucy Mackillop, clinical lead for the development of GDm-Health, said: “Through GDm-Health, we have been able to make a real, tangible difference to the lives of women during pregnancy.

“We are very pleased with the rapid uptake of GDm-Health by NHS Trusts, and thrilled by the recognition of this HSJ award. With GDM becoming more prevalent, it is vital that the latest technological insights available be utilised to help women and their clinicians better manage this condition.”

Lord Drayson, CEO of Sensyne Health,said: “GDm-Health is a great example of a healthcare innovation that has been invented in the NHS and that has enormous potential to improve health, both in the UK and internationally.”

← Oxford BRC welcomes visitors to expand international links
Athena SWAN “Europe’s most comprehensive gender equality scheme” →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre